Durable response to pralatrexate for aggressive PTCL subtypes

被引:0
|
作者
Farhan, Ahmed [1 ]
Strelec, Lauren E. [1 ]
Schuster, Stephen J. [1 ]
Torigian, Drew [1 ]
Wasik, Mariusz [1 ]
Sadigh, Sam [1 ]
Mato, Anthony R. [1 ]
Nasta, Sunita Dwivedy [1 ]
Frank, Dale [1 ]
Svoboda, Jakub [1 ]
机构
[1] Univ Penn, Abrahamson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA
来源
关键词
D O I
10.12788/jcso.0369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E102 / E105
页数:4
相关论文
共 50 条
  • [21] Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
    Arranto, Christian
    Tzankov, Alexandar
    Halter, Jorg
    ANNALS OF HEMATOLOGY, 2017, 96 (04) : 681 - 682
  • [22] Blastic plasmacytoid dendritic cell neoplasm with transient response to pralatrexate
    Christian Arranto
    Alexandar Tzankov
    Jörg Halter
    Annals of Hematology, 2017, 96 : 681 - 682
  • [23] Durable Performance of Recycled Aggregate Concrete in Aggressive Environments
    Zega, Claudio J.
    Santillan, Lautaro R.
    Sosa, Maria E.
    Villagran Zaccardi, Yury A.
    JOURNAL OF MATERIALS IN CIVIL ENGINEERING, 2020, 32 (07)
  • [24] Immune checkpoints in aggressive breast cancer subtypes
    Zawlik, I.
    Gablo, N.
    Szymanska, B.
    Pawlowska, Z.
    Chudobinski, C.
    Chalubinska-Fendler, J.
    Morawiec, Z.
    Zielinska-Blizniewska, H.
    Morawiec-Sztandera, A.
    Kolacinska, A.
    NEOPLASMA, 2016, 63 (05) : 768 - 773
  • [25] AGGRESSIVE RESPONSE
    NORTHUP, GW
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1979, 79 (04): : 221 - 222
  • [26] PROPEL: Results of the pivotal, multicenter, phase II study of pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)
    O'Connor, O.
    Pro, B.
    Pinter-Brown, L.
    Popplewell, L.
    Bartlett, N.
    Lechowicz, M.
    Savage, K.
    Coiffier, B.
    Saunders, M.
    Horwitz, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [27] THE AGGRESSIVE RESPONSE
    RIVERA, MJ
    PSYCHOLOGY TODAY, 1988, 22 (09) : 78 - 78
  • [28] PRALATREXATE-BASED THERAPY INDUCED RESPONSE IN AN ADOLESCENT WITH REFRACTORY HSTL
    Dhir, Aditi
    Hill, Benjamin
    Waite, Emily
    Cairo, Mitchell
    Xavier, Ana
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S191 - S192
  • [29] Pralatrexate injection combined with CHOP for treatment of PTCL: results from the Fol-CHOP dose-finding phase 1 trial
    Iyer, Swaminathan P.
    Johnston, Patrick B.
    Barta, Stefan K.
    BLOOD ADVANCES, 2024, 8 (02) : 353 - 364
  • [30] Pralatrexate Is Effective In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with Prior Ifosfamide, Carboplatin, and Etoposide (ICE)-Based Regimens
    Goy, Andre
    Pro, Barbara
    Savage, Kerry Joanne
    Bartlett, Nancy L.
    Lechowicz, Mary Jo
    Jacobsen, Eric D.
    Young, Faith
    Crump, Michael
    Borghaei, Hossein
    Link, Brian
    Fruchtman, Steven M.
    O'Connor, Owen A.
    BLOOD, 2010, 116 (21) : 731 - 732